Early intervention in psychosis: p-values, policy, and politics

World Psychiatry

Volumn 16, Issue 3, 2017, Pages 270-271

  Rosenheck, Robert ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ANTIRETROVIRAL THERAPY; CANCER RESEARCH; CAREGIVER BURDEN; CLINICAL EFFECTIVENESS; COST EFFECTIVENESS ANALYSIS; DEPRESSION; DISEASE COURSE; EARLY INTERVENTION; EPIDEMIC; GLOBAL DISEASE BURDEN; HEALTH CARE COST; HEALTH CARE SYSTEM; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIFE EXPECTANCY; NOTE; PATIENT SATISFACTION; POLITICS; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; RELAPSE; SCHIZOPHRENIA; SOCIAL PARTICIPATION; SUBSTANCE USE; TREATMENT OUTCOME; TRUST;

EID: 85029714356     PISSN: 17238617     EISSN: 20515545     Source Type: Journal    
DOI: 10.1002/wps.20450     Document Type: Note

References (9)

1. Fusar-Poli P, McGorry PD, Kane JM. World Psychiatry 2017;16:251-65.
2. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Lancet 2016;388:1545-602.
3. Kane JM, Robinson DG, Schooler NR et al. Am J Psychiatry 2016;173:362-72.
4. Park AL, McCrone P, Knapp M. Early Interv Psychiatry 2016;10:144-51.
5. Csillag C, Nordentoft M, Mizuno M et al. Early Interv Psychiatry 2016;10:540-6.
6. Rosenheck R, Leslie D, Sint K et al. Schizophr Bull 2016;42:896-906.
7. Varmus H. Science & Diplomacy 2013;2:4.
8. Office of the United States Global AIDS Coordinator. Congressional budget justification supplement. Fiscal year 2016. www.pepfar.gov.
9. Marcus JL, Chao C, Leyden W et al. Narrowing the gap in life expectancy for HIV+ compared with HIV- individuals. Presented at the Conference on Retroviruses and Opportunistic Infections, Boston, February 2016.